Biocad begins deliveries of Sputnik-V for large-scale vaccination in Russia

2020: Start of supply of Sputnik-V vaccine for large-scale vaccination in Russia

Biotech company Biocad has begun to supply COVID-19 vaccine to the Gamalei Center for large-scale vaccination against coronavirus in the country. This was announced by Biocad on December 16, 2020.

The decision to produce the Sputnik-V vaccine at the BIOCAD facilities was made in early September, "said Dmitry Morozov, CEO of BIOCAD. - We managed to deploy a full-fledged vaccine production in a very short time. More than 400 of our employees are involved in vaccine projects and about 500 million rubles of their own funds have already been invested.

The agreement with the Gamalei Center was signed on September 21, 2020, and a little later the company reported that Biocad plans to release 1 million doses of the vaccine in December 2020. Over time, the company intends to increase output to 3-4 million doses per month in order to maximize the closure of the country's internal need for a vaccine.

On December 14, 2020, the biotechnology company BIOCAD production site was included in the registration certificate of the Gamalei Center for the production of the Sputnik-V coronavirus vaccine Minister of Health RUSSIAN FEDERATION Mikhail Murashko. reported that coronavirus vaccine they delivered to all regions, Russia vaccination began in all subjects of the country.